Results 221 to 230 of about 424,050 (291)

AXL-SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers. [PDF]

open access: yesNPJ Precis Oncol
Ishida M   +27 more
europepmc   +1 more source

USP54 Promotes Ferroptosis in Non‐Small Cell Lung Cancer by Mediating FOXA2 Deubiquitination and Enhancing ACSL4 Transcription

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Non‐small cell lung cancer (NSCLC) is the most common type of lung cancer, with a 5‐year survival rate of less than 20% and a high risk of recurrence despite advances in treatment. This study aimed to identify new therapeutic targets to increase the effectiveness of NSCLC treatments.
Rui‐Shi Wei   +5 more
wiley   +1 more source

Cytotoxic effect of famotidine in breast adenocarcinoma cells line. [PDF]

open access: yesNorth Clin Istanb
Kaskal M   +3 more
europepmc   +1 more source

RTA‐408 Enhances Radiosensitivity and Inhibited Tumor Progression via JNK Pathway in Glioblastoma

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis owing to its high invasiveness and resistance to therapy. RTA‐408, a synthetic triterpenoid and nuclear factor erythroid 2‐related factor 2 activator, exhibits anti‐inflammatory and anti‐cancer properties; however, its effects on GBM remain unclear. This study investigated the
Hung‐Pei Tsai   +6 more
wiley   +1 more source

Medulloblastoma response to mevalonate pathway inhibition is independent of p53 status. [PDF]

open access: yesBiol Direct
Comer C   +8 more
europepmc   +1 more source

Differential working memory changes following methylphenidate in medication-naive and medication-experienced adults with ADHD. [PDF]

open access: yesPCN Rep
Shimizu M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy